References
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211–1259.
- Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention, Updated 2020, 2020. Available from: http://www.ginasthma.org [last accessed cited 1 November 2020].
- British guideline on asthma management, updated 2019, 2019. Available from: https://brit-thoracic.org.uk/quality-improvement/guidelines/asthma/ [last accessed 1 December 2019].
- The global asthma report 2018. Available from: http://www.globalasthmareport.org/resources/global_asthma_report_2018.pdf [last accessed 1 December 2018]
- Schatz M, Meckley LM, Kim M, Stockwell BT, Castro M. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. Allergy Clin Immunol Pract 2014;2(5):570–574. doi:https://doi.org/10.1016/j.jaip.2014.05.002.
- Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ. Measuring the cost of poor asthma control and exacerbations. J Asthma 2017;54(1):24–31. doi:https://doi.org/10.1080/02770903.2016.1194430.
- Boonsawat W, Thompson PJ, Zaeoui U, Samosorn C, Acar G, Faruqi R, Poonnoi P. Survey of asthma management in Thailand – the asthma insight and management study. Asian Pac J Allergy Immunol 2015;33(1):14–20. doi:https://doi.org/10.12932/AP0473.33.1.2015.
- Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Pothirat C, Thanomsieng N. Survey of asthma control in Thailand. Respirology 2004;9(3):373–378. doi:https://doi.org/10.1111/j.1440-1843.2004.00584.x.
- Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004;125(3):1081–1102. doi:https://doi.org/10.1378/chest.125.3.1081.
- Gonzalez-Barcala F-J, Calvo-Alvarez U, Garcia-Sanz M-T, Garcia-Couceiro N, Martin-Lancharro P, Pose A, Carreira J-M, Moure-Gonzalez J-D, Valdes-Cuadrado L, Muñoz X, et al. Asthma exacerbations: risk factors for hospital readmissions. Ir J Med Sci 2018;187(1):155–161. doi:https://doi.org/10.1007/s11845-017-1633-9.
- McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR. Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol 2006;118(6):1226–1233. doi:https://doi.org/10.1016/j.jaci.2006.09.006.
- Meltzer EO, Busse WW, Wenzel SE, Belozeroff V, Weng HH, Feng J, Chon Y, Chiou CF, Globe D, Lin SL. Use of the asthma control questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011;127(1):167–172. doi:https://doi.org/10.1016/j.jaci.2010.08.042.
- Schatz M, Zeiger RS, Yang SJ, Chen W, Crawford W, Sajjan S, Allen-Ramey F. The relationship of asthma impairment determined by psychometric tools to future asthma exacerbations. Chest 2012;141(1):66–72. doi:https://doi.org/10.1378/chest.11-0574.
- Patel M, Pilcher J, Reddel HK, Pritchard A, Corin A, Helm C, Tofield C, Shaw D, Black P, Weatherall M, et al.; SMART Study Group, Metrics of salbutamol use as predictors of future adverse outcomes in asthma. Clin Exp Allergy 2013;43(10):1144–1151. doi:https://doi.org/10.1111/cea.12166.
- Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin JF, McNutt M, Buist AS. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268(24):3462–3464.
- Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105(6):930–938. doi:https://doi.org/10.1016/j.rmed.2011.01.005.
- Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009;33(4):897–906. doi:https://doi.org/10.1183/09031936.00121308.
- Osborne ML, Pedula KL, O'Hollaren M, Ettinger KM, Stibolt T, Buist AS, Vollmer WM. Assessing future need for acute care in adult asthmatics: the profile of asthma risk study: a prospective health maintenance organization-based study. Chest 2007;132(4):1151–1161. doi:https://doi.org/10.1378/chest.05-3084.
- Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, FitzGerald JM. Risk factors for near-fatal asthma. A case–control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998;157(6 Pt 1):1804–1809. doi:https://doi.org/10.1164/ajrccm.157.6.9708092.
- Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101(3):481–489. doi:https://doi.org/10.1016/j.rmed.2006.07.005.
- Arrotta N, Hill J, Villa-Roel C, Dennett E, Harries M, Rowe BH. Factors associated with hospital admission in adult patients with asthma exacerbations: a systematic review. J Asthma 2019;56(1):34–41. doi:https://doi.org/10.1080/02770903.2018.1424189.
- Gonzalez-Barcala FJ, Aboal J, Valdes L, Carreira JM, Alvarez-Dobaño JM, Puga A, Garcia-Sanz MT, Takkouche B. Trends in adult asthma hospitalization: gender-age effect. Multidiscip Respir Med 2011;6(2):82–86. doi:https://doi.org/10.1186/2049-6958-6-2-82.
- Mallah N, Rodriguez-Segade S, Gonzalez-Barcala FJ, Takkouche B. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis. Pediatr Allergy Immunol. In press. [cited 2020 Nov 2]. Epub ahead of print. doi:https://doi.org/10.1111/pai.13403.
- Alvarez GG, Schulzer M, Jung D, Fitzgerald JM. A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J 2005;12(5):265–270. doi:https://doi.org/10.1155/2005/837645.
- Pendergraft TB, Stanford RH, Beasley R, Stempel DA, Roberts C, McLaughlin T. Rates and characteristic of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol 2004;93(1):29–35. doi:https://doi.org/10.1016/S1081-1206(10)61444-5.
- Gonzalez-Barcala FJ, Calvo-Alvarez U, Garcia-Sanz MT, Bourdin A, Pose-Reino A, Carreira JM, Moure-Gonzalez JD, Garcia-Couceiro N, Valdes-Cuadrado L, Muñoz X. Characteristics and prognosis of near-fatal asthma exacerbations. Am J Med Sci 2015;350(2):98–102. doi:https://doi.org/10.1097/MAJ.0000000000000518.
- Abdelkarim H, Durie M, Bellomo R, Bergmeir C, Badawi O, El-Khawas K, Pilcher D. A comparison of characteristics and outcomes of patients admitted to the ICU with asthma in Australia and New Zealand and United states. J Asthma 2020;57(4):398–404. doi:https://doi.org/10.1080/02770903.2019.1571082.
- Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep 2017;17(3):19. doi:https://doi.org/10.1007/s11882-017-0686-1.
- Takeda M, Tanabe M, Ito W, Ueki S, Konnno Y, Chihara M, Itoga M, Kobayashi Y, Moritoki Y, Kayaba H, et al. Gender difference in allergic airway remodelling and immunoglobulin production in mouse model of asthma. Respirology 2013;18(5):797–806. doi:https://doi.org/10.1111/resp.12078.
- Vedel-Krogh S, Nielsen SF, Lange P, Vestbo J, Nordestgaard BG. Association of blood eosinophil and blood neutrophil counts with asthma exacerbations in the Copenhagen general population study. Clin Chem 2017;63(4):823–832. doi:https://doi.org/10.1373/clinchem.2016.267450.
- Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24(5):822–833. doi:https://doi.org/10.1183/09031936.04.00039004.
- Gonzalez-Barcala FJ, Calvo-Alvarez U, Salgado-Castro FJ, Facal D, Garcia-Sanz MT, Muñoz X, Garcia-Couceiro N, Paz-Neira O, San-Jose E, Valdes-Cuadrado L, et al. Asthma exacerbations: factors related to longer hospital stay. Acta Clin Belg 2017;72(6):379–384. doi:https://doi.org/10.1080/17843286.2017.1295524.
- Price D, Wilson AM, Chisholm A, Rigazio A, Burden A, Thomas M, King C. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016;9:1–12.
- Soler-Cataluña JJ, Novella L, Soler C, Nieto ML, Esteban V, Sánchez-Toril F, Miravitlles M. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap. Arch Bronconeumol 2020;56(5):282–290. doi:https://doi.org/10.1016/j.arbres.2019.08.023.
- Pollock M, Sinha IP, Hartling L, Rowe BH, Schreiber S, Fernandes RM. Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews. Allergy 2017;72(2):183–200. doi:https://doi.org/10.1111/all.13039.
- González-García JG, Chalela R, Carballo N, Ausín P. Mild asthma and life-threatening exacerbations: is it time to take action? Arch Bronconeumol 2020;56(6):395–396. doi:https://doi.org/10.1016/j.arbres.2019.11.028.
- Muñoz X, Romero-Mesones C, Cruz MJ. β2-Agonists in asthma: the strange case of Dr. Jekyll and Mr. Hyde. Arch Bronconeumol 2020;56(4):204–205. doi:https://doi.org/10.1016/j.arbres.2019.07.003.
- Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343(5):332–336. doi:https://doi.org/10.1056/NEJM200008033430504.